Study of Jitongning Tablet to Treat Spondyloarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

June 20, 2021

Study Completion Date

August 20, 2021

Conditions
Spondyloarthritis
Interventions
DRUG

Jitongning tablet(High-dose )

Jitongning tablet,3tablets,bid,treat 12 weeks

DRUG

Jitongning tablet(Low-dose )

Jitongning tablet,2tablets,bid,treat 12 weeks Jitongning tablet placebo,1tablet,bid,treat 12 weeks

DRUG

Placebo

Jitongning tablet placebo,3tablets,bid,treat 12 weeks

Trial Locations (11)

Unknown

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

The First Affiliated Hospital of hunan Medical University, Changsha

Jiangsu Province Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing

Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin

The First Affiliated Hospital of Kunming Medical University, Kunming

Yunnan Province Hospital of Traditional Chinese Medicine, Kunming

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai

All Listed Sponsors
lead

Tasly Pharmaceutical Group Co., Ltd

INDUSTRY

NCT03932019 - Study of Jitongning Tablet to Treat Spondyloarthritis | Biotech Hunter | Biotech Hunter